| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00406-018-0905-3 |
| P698 | PubMed publication ID | 29845446 |
| P50 | author | Wagner Farid Gattaz | Q20742758 |
| P2093 | author name string | Leda Leme Talib | |
| Orestes Vicente Forlenza | |||
| Jessyka Maria de França Bram | |||
| Helena Passarelli Giroud Joaquim | |||
| Tamires Alves Sarno | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10 | Q21562503 | ||
| Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE | Q22010705 | ||
| [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients | Q24676332 | ||
| “Mini-mental state” | Q25938989 | ||
| Platelet biomarkers in Alzheimer's disease | Q26858851 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| It all sticks together--the APP-related family of proteins and Alzheimer's disease | Q28138947 | ||
| Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14 | Q28156208 | ||
| Amyloid precursor protein and amyloid beta peptide in human platelets. Role of cyclooxygenase and protein kinase C | Q28181130 | ||
| The ADAM metalloproteinases | Q28292696 | ||
| Gamma-secretase complex assembly within the early secretory pathway | Q28297818 | ||
| The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
| Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade | Q29614407 | ||
| Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. | Q30336360 | ||
| BACE1 and BACE2 enzymatic activities in Alzheimer's disease | Q33643141 | ||
| Phosphorylated Presenilin 1 decreases β-amyloid by facilitating autophagosome-lysosome fusion | Q33887101 | ||
| The future of blood-based biomarkers for Alzheimer's disease | Q34026317 | ||
| Platelets as a peripheral district where to study pathogenetic mechanisms of alzheimer disease: the case of amyloid precursor protein. | Q34061055 | ||
| BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology | Q43158562 | ||
| Tau, APP, NCT and BACE1 in lymphocytes through cognitively normal ageing and neuropathology | Q43736622 | ||
| ADAM10 as a biomarker for Alzheimer's disease: a study with Brazilian elderly | Q43857484 | ||
| Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease | Q44060098 | ||
| Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease | Q44132132 | ||
| Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI). | Q44257894 | ||
| Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease | Q44270458 | ||
| Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9. | Q44486768 | ||
| Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets | Q44642575 | ||
| Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet | Q48094420 | ||
| Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment | Q48147007 | ||
| A strategy focused on MAPT, APP, NCSTN and BACE1 to build blood classifiers for Alzheimer's disease | Q48235243 | ||
| Detection of a soluble form of BACE-1 in human cerebrospinal fluid by a sensitive activity assay | Q48584977 | ||
| Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease | Q48882042 | ||
| Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic | Q49135523 | ||
| Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. | Q51013219 | ||
| Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets | Q51061879 | ||
| CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia | Q52077039 | ||
| Altered amyloid protein processing in platelets of patients with Alzheimer disease | Q53216222 | ||
| Alzheimer disease-related abnormalities of amyloid beta precursor protein isoforms in the platelet: the brain's delegate in the periphery? | Q53224145 | ||
| Protein markers for Alzheimer disease in the frontal cortex and cerebellum | Q53265113 | ||
| CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias. | Q53280434 | ||
| Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease | Q53300387 | ||
| Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease | Q53328612 | ||
| Coordinated Expression of β-Amyloid Precursor Protein and the Putative β-Secretase BACE and α-Secretase ADAM10 in Mouse and Human Brain | Q57268718 | ||
| Differential Level of Platelet Amyloid beta Precursor Protein Isoforms: An Early Marker for Alzheimer Disease | Q62066127 | ||
| Blood platelets as models for neurons: uses and limitations | Q71987946 | ||
| Proteolytic processing of Alzheimer's disease beta A4 amyloid precursor protein in human platelets | Q72298778 | ||
| Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets | Q74493515 | ||
| Targeting the β secretase BACE1 for Alzheimer's disease therapy | Q34405667 | ||
| Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease | Q34419817 | ||
| The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis | Q34421800 | ||
| Platelets, a reliable source for peripheral Alzheimer's disease biomarkers? | Q34500658 | ||
| Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease | Q34680488 | ||
| Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease | Q34807142 | ||
| Platelet-derived secreted amyloid-precursor protein-β as a marker for diagnosing Alzheimer's disease | Q35029908 | ||
| The ADAMs family of metalloproteases: multidomain proteins with multiple functions | Q35039313 | ||
| The pharmacology of amyloid precursor protein processing. | Q35051367 | ||
| Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex | Q35105866 | ||
| Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease | Q35284971 | ||
| BACE1 as a Potential Biomarker for Alzheimer's Disease | Q35856328 | ||
| Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease. | Q35943860 | ||
| Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease. | Q36037981 | ||
| Alzheimer disease and platelets: how’s that relevant | Q36535484 | ||
| Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study | Q36538745 | ||
| Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes | Q36687762 | ||
| What's new in using platelet research? To unravel thrombopathies and other human disorders | Q36874262 | ||
| Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia | Q36933691 | ||
| Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature | Q36948436 | ||
| Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems | Q36997922 | ||
| BACE1 structure and function in health and Alzheimer's disease | Q37130637 | ||
| Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease | Q37224550 | ||
| The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions | Q37339450 | ||
| Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study | Q37725038 | ||
| The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease | Q37884646 | ||
| Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging | Q37956562 | ||
| Identification and biology of α-secretase. | Q37961730 | ||
| Role of platelets in neurodegenerative diseases: a universal pathophysiology | Q38072757 | ||
| A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood | Q38653401 | ||
| Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease. | Q38988833 | ||
| Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms | Q39214249 | ||
| Increase of α-Secretase ADAM10 in Platelets Along Cognitively Healthy Aging | Q39285908 | ||
| Alzheimer's presenilin 1 gene expression in platelets and megakaryocytes. Identification of a novel splice variant | Q41168609 | ||
| Alzheimer beta A4-amyloid protein precursor in immunocompetent cells | Q41593806 | ||
| Characterization of Alzheimer amyloid precursor protein transcripts in platelets and megakarocytes | Q41628054 | ||
| Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. | Q41746563 | ||
| Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline | Q42172083 | ||
| Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease | Q42414341 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 963-972 | |
| P577 | publication date | 2018-05-29 | |
| P1433 | published in | European Archives of Psychiatry and Clinical Neuroscience | Q661388 |
| P1476 | title | Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients | |
| P478 | volume | 269 |
Search more.